๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Efmoroctocog alfa - Medicines in Ireland

8 authorised products containing Efmoroctocog alfa, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 8 authorised medicines
MedicineActive substanceLicence holderStatus
ELOCTA 1000 IU powder and solvent for solution for injection
EU/1/15/1046/004
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 1500 IU powder and solvent for solution for injection
EU/1/15/1046/005
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 2000 IU powder and solvent for solution for injection
EU/1/15/1046/006
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 250 IU powder and solvent for solution for injection
EU/1/15/1046/001
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 3000 IU powder and solvent for solution for injection
EU/1/15/1046/007
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 4000 IU powder and solvent for solution for injection
EU/1/15/1046/008
Efmoroctocog alfa Swedish Orphan Biovitrum AB(publ) โ€”
ELOCTA 500 IU powder and solvent for solution for injection
EU/1/15/1046/002
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
ELOCTA 750 IU powder and solvent for solution for injection
EU/1/15/1046/003
Efmoroctocog alfa Swedish Orphan Biovitrum AB โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.